Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia

Francesco d’Amore Lauri A. Aaltonen Department of Medical Genetics, University of Helsinki, Research Programmes Unit, Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland, Department of Haematology, Aarhus University Hospital, Aarhus, Denmark, Department of Oncology, Helsinki University Central Hospital Cancer Centre, and Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland E-mail: lauri.aaltonen@helsinki.fi

[1]  Hyewon Chung,et al.  Change of retinal nerve fiber layer thickness in various retinal diseases treated with multiple intravitreal antivascular endothelial growth factor. , 2014, Investigative ophthalmology & visual science.

[2]  M. Kersten,et al.  Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Giorgia Maraone,et al.  Intravitreal Injection of Dexamethasone Implant in Serous Macular Detachment Associated with Waldenström's Disease , 2013, Case Reports in Ophthalmology.

[4]  G. Staurenghi,et al.  Serous macular detachment in Waldenström macroglobulinemia: a report of 4 cases. , 2013, American journal of ophthalmology.

[5]  I. Tajunisah,et al.  Intravitreal Bevacizumab for Radiation-Induced Cystoid Macular Oedema in Patients with Nasopharyngeal Carcinoma: A Clinical Series , 2013, Ophthalmologica.

[6]  Gary C. Brown,et al.  Serous macular detachment in Waldenström macroglobulinemia: a report of four cases. , 2013, American journal of ophthalmology.

[7]  Mark W. Johnson,et al.  Immunogammopathy maculopathy associated with Waldenström macroglobulinemia is refractory to conventional interventions for macular edema. , 2013, Retinal cases & brief reports.

[8]  A. Foss,et al.  Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in Waldenstrom's macroglobulinaemia , 2008, Eye.

[9]  M. Dimopoulos,et al.  Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. , 2003, Seminars in oncology.